129 related articles for article (PubMed ID: 29970180)
1. Immunohistochemical over expression of p53 in head and neck Squamous cell carcinoma: clinical and prognostic significance.
Hashmi AA; Hussain ZF; Hashmi SK; Irfan M; Khan EY; Faridi N; Khan A; Edhi MM
BMC Res Notes; 2018 Jul; 11(1):433. PubMed ID: 29970180
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.
Hashmi AA; Hussain ZF; Aijaz S; Irfan M; Khan EY; Naz S; Faridi N; Khan A; Edhi MM
World J Surg Oncol; 2018 Jun; 16(1):118. PubMed ID: 29954411
[TBL] [Abstract][Full Text] [Related]
3. p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma.
Oridate N; Homma A; Higuchi E; Suzuki F; Hatakeyama H; Mizumachi T; Furusawa J; Taki S; Furuta Y; Fukuda S
Auris Nasus Larynx; 2009 Feb; 36(1):57-63. PubMed ID: 18472237
[TBL] [Abstract][Full Text] [Related]
4. Study of the diagnosis and treatment of cancer located in the head and neck and correlation with expression of prognostic markers.
Bădulescu F; Bădulescu A; Crişan A; Popescu FC
Rom J Morphol Embryol; 2013; 54(3):487-97. PubMed ID: 24068395
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of microvessel density and p53 expression on the locoregional metastasis and survival of the patients with head and neck squamous cell carcinoma.
de Oliveira MV; Pereira Gomes EP; Pereira CS; de Souza LR; Barros LO; Mendes DC; Guimarães AL; De Paula AM
Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):444-51. PubMed ID: 23343952
[TBL] [Abstract][Full Text] [Related]
6. P53 overexpression in epidermoid carcinoma of the head and neck.
Logullo AF; Kowalski LP; Nonogaki S; Miguel RE; Torloni H; Brentani RR
Sao Paulo Med J; 1997; 115(1):1349-55. PubMed ID: 9293116
[TBL] [Abstract][Full Text] [Related]
7. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tumor suppressor p53 status in head and neck squamous cell carcinoma.
Smardova J; Ksicova K; Binkova H; Krpensky A; Pavlova S; Rottenberg J; Koukalova H
Oncol Rep; 2004 Apr; 11(4):923-9. PubMed ID: 15010896
[TBL] [Abstract][Full Text] [Related]
9. No prognostic significance of p53 expression in esophageal squamous cell carcinoma.
Kanamoto A; Kato H; Tachimori Y; Watanabe H; Nakanishi Y; Kondo H; Yamaguchi H; Gotoda T; Muro K; Matsumura Y
J Surg Oncol; 1999 Oct; 72(2):94-8. PubMed ID: 10518106
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.
Sakashita T; Homma A; Suzuki S; Hatakeyama H; Kano S; Mizumachi T; Oridate N; Fukuda S
Acta Otolaryngol; 2013 Sep; 133(9):984-91. PubMed ID: 23692432
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx.
Salerno G; Di Vizio D; Staibano S; Mottola G; Quaremba G; Mascolo M; Galli V; De Rosa G; Insabato L
BMC Cancer; 2006 Jun; 6():146. PubMed ID: 16740156
[TBL] [Abstract][Full Text] [Related]
14. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
Golusiński W; Golusiński P; Stańczak J; Kłosin J
Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of p53 overexpression in head and neck carcinomas: a pilot study.
Ghoshal S; Dey P; Saikia UN; Sharma SC
Anal Quant Cytol Histol; 2002 Oct; 24(5):254-6. PubMed ID: 12408557
[TBL] [Abstract][Full Text] [Related]
16. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy.
Hitt R; Ciruelos E; Amador ML; Benito A; Sanchez JJ; Ballestin C; Cortes-Funes H
Eur J Cancer; 2005 Feb; 41(3):453-60. PubMed ID: 15691646
[TBL] [Abstract][Full Text] [Related]
18. [No association between p53 overexpression and polarographically measured tumor oxygenation in patients with head and neck carcinomas].
Becker A; Stadler P; Krause U; Kuhnt T; Hänsgen G; Dettmar P; Feldmann HJ; Rath FW; Molls M; Dunst J
Strahlenther Onkol; 2000 Oct; 176(10):475-80. PubMed ID: 11068594
[TBL] [Abstract][Full Text] [Related]
19. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization.
De Paula AM; Souza LR; Farias LC; Corrêa GT; Fraga CA; Eleutério NB; Silveira AC; Santos FB; Haikal DS; Guimarães AL; Gomez RS
Oral Oncol; 2009 Sep; 45(9):777-82. PubMed ID: 19359212
[TBL] [Abstract][Full Text] [Related]
20. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
